Mike F. Gordeev
Chief Scientific Officer
Medicine
MicuRX Pharmaceuticals
China
Biography
Dr. Gordeev co-founded MicuRx to apply his core expertise in medicinal chemistry with an emphasis on the design, identification, and IND-enablement of anti-infective agents. Prior to MicuRx, he was vice president of medicinal chemistry at Vicuron Pharmaceuticals Inc. where he led several major internal and big pharma collaborations that resulted in small molecule and natural product antibiotics. Prior to Vicuron, Mike held positions of increasing responsibility at GlaxoWellcome and Affymax. Previously, he served in scientific roles at Alan Katritzky’s Center for Heterocyclic Compounds at the University of Florida (Gainesville) and Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences (Moscow). Dr. Gordeev received his M.S. and Ph.D. in organic chemistry from Moscow State University. He has authored over 100 peer-reviewed publications and multiple issued patents.
Research Interest
medicinal chemistry , Design
